- Report
- December 2025
- 139 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- December 2025
- 130 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- November 2025
- 160 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- October 2025
- 85 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- October 2025
- 160 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- September 2025
- 160 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- September 2025
- 145 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- September 2025
- 138 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- July 2025
- 136 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- July 2025
- 130 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- June 2025
- 134 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- June 2025
- 130 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- May 2025
- 130 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- May 2025
- 210 Pages
Global
From €3923EUR$4,500USD£3,412GBP
- Report
- April 2025
- 120 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- March 2025
- 76 Pages
Global
From €3047EUR$3,495USD£2,650GBP
- Report
- March 2025
- 75 Pages
Global
From €3047EUR$3,495USD£2,650GBP
- Report
- March 2025
- 220 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- February 2025
- 132 Pages
Global
From €4229EUR$4,850USD£3,677GBP
- Report
- June 2025
- 150 Pages
United States
From €5188EUR$5,950USD£4,511GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more